Association of human FcγRIIa (CD32) polymorphism with susceptibility to and severity of meningococcal disease

Clinical Infectious Diseases

Volumn 27, Issue 4, 1998, Pages 746-750

  Platonov, Alexander E ^b   Shipulin, German A ^b   Vershinina, Irina V ^b   Dankert, Jacob ^b   Van De Winkel, Jan G J ^b   Kuijper, Ed J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN RECEPTOR;

ADOLESCENT; ADULT; ALLOTYPE; ANTIBIOTIC SENSITIVITY; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; PHAGOCYTOSIS; PRIORITY JOURNAL;

EID: 2442767009     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514935     Document Type: Article

References (28)

1. Noah N, Connolly M. Surveillance of bacterial meningitis in Europe 1995. London: King's College London, 1996.
2. Bone RC. The pathogenesis of sepsis. Ann Intern Med 1991; 115:457-69.
3. Brandtzaeg P. Pathogenesis of meningococcal infections. In: Cartwright K, ed. Meningococcal disease. Chichester, England: John Wiley & Sons, 1995:71-115.
4. Bredius RGM, Derkx BHF, Fijen CAP, et al. Fey receptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children. J Infect Dis 1994; 170:848-53.
5. Goldschneider I, Gotschlich EC, Artenstein MS. Human immunity to the meningococcus. II. Development of natural immunity. J Exp Med 1969; 129:1327-48.
6. Griffiss JM. Mechanism of host immunity. In: Meningococcal disease. Cartwright K, ed. Chichester, England: John Wiley & Sons, 1995:35-71.
7. Platonov AE, Beloborodov VB, Vershinina IV. Meningococcal disease in patients with late complement components deficiency: studies in the USSR. Medicine (Baltimore) 1993; 72:374-92.
8. Bredius RG, de Vries CEE, Troelstra A, et al. Phagocytosis of Staphylococcus aureus and Haemophilus influenzae type B opsonized with polyclonal human IgG1 and IgG2 antibodies. J Immunol 1993; 151:1463-72.
9. Sanders LAM, Feldman RG, Voorhorst-Ogink MM, et al. Human immunoglobulin G (IgG) Fc receptor HA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils. Infect Immun 1995;63: 73-81.
10. Bredius RG, Fijen CA, De Haas M, et al. Role of neutrophil Fc gamma RIIa (CD32) and Fc gamma RIIIb (CD 16) polymorphic forms in phagocytosis of human IgG1-and IgG3-opsonized bacteria and erythrocytes. Immunology 1994; 83:624-30.
11. Deo YM, Graziano RF, Repp R, van de Winkel JGJ. Clinical significance of IgG Fc receptors and FcyR-directed immunotherapies. Immunol Today 1997; 18:127-35.
12. Warmerdam PAM, van de Winkel JGJ, Vlug A, Westerdaal NA, Capel PJ. A single amino acid in the second IgG-like domain of the human Fcγ receptor IIa is critical for human IgG2 binding. J Immunol 1991; 147:1338-43.
13. Hermann DJ, Hamilton RG, Barington T, et al. Quantitaten of human IgG subclass antibodies to Haemophilus influenzae type b capsular polysaccharide. J Immunol Methods 1992; 148:101-14.
14. Siber GR, Schur PH, Aisenberg AC, Weitzman SA, Shiffman G. Correlation between serum IgG2 concentrations and the antibody response to bacterial polysaccharide antigens. N Engl J Med 1980;303:178-82.
15. Platonov AE, Koroleva IS, Shipulin GA, Shipulina OJ, Vershinina IV, Dankert J. Comparison of different methods to diagnose bacterial meningitis in Russia. In: Zollinger WD, Frasch CE, Deal CD, eds. Pathogenic Neisseria. 1996:515-6.
16. Ni H, Knight AI, Cartwright K, Palmer WH, McFadden J. Polymerase chain reaction for diagnosis of meningococcal meningitis. Lancet 1992; 340:1432-4.
17. Radstrom P, Backman A, Qlan N, Kragsbjerg P, Pahlson C, Olsen P. Detection of bacterial DNA in cerebrospinal fluid by an assay for simultaneous detection of Neisseria meningitidis. Haemophilus influenzae, and streptococci using a seminested PCR strategy. J Clin Microbiol 1994; 32:2738-44.
18. Martin MA, Silverman HJ. Gram-negative sepsis and the adult respiratory distress syndrome. Clin Infect Dis 1992; 14:1213-28.
19. Boom R, Sol CJA, Salimans MMM, et al. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990; 28:495-503.
20. Osborne JM, Chacko GW, Brandt JT, Anderson CL. Ethnic variation in frequency of an allelic polymorphism of human FcγRIIA determined with allele-specific oligonucleotide probes. J Immunol Methods 1994; 173:207-17.
21. Altman DG. Practical statistics for medical research. London: Chapman & Hall, 1991.
22. Figueroa JE, Densen P. Infectious diseases associated with complement deficiencies. Clin Microbiol Rev 1991; 4:359-95.
23. Fijen CAP, Kuijper EJ, Hannema AJ, Sjoholm AG, van Putten JPM. Complement deficiencies in patients over ten years old with meningo-coccal disease due to uncommon serogroups. Lancet 1989; 2:585-88.
24. Fijen CAP, Bredius RGM, Kuijper EJ. Polymorphism of IgG Fc receptors in meningococcal disease. Ann Intern Med 1993; 119:636.
25. Platonov AE, Kuijper EJ, Vershinina IV, et al. Meningococcal disease and polymorphism of FcγRIIa (CD32) in late complement component deficient individuals. Clin Exp Immunol 1998; 111:97-101.
26. Jones SL, Brown EJ. Functional cooperation between Fcγ receptors and complement receptors in phagocytes. In: van de Winkel JGJ, Capel PJA, eds. Human IgG Fc receptors. Austin, Texas: RG Landes Company, 1996:148-63.
27. Nadel S, Newport MJ, Booy R, Levin M. Variation in the tumor necrosis factor-α gene promoter region may be associated with death from meningococcal disease. J Infect Dis 1996; 174:878-80.
28. Westendorp RGj, Langermans JAM, Huizinga TWJ, et al. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997; 49:170-4.